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The identification of L-asparaginase  as the constituent of guinea pig serum 
responsible for its tumor-inhibitory properties is now generally accepted (1-5). 
A number of other asparaginases having high substrate avidity have recently 
been found to ~nh~bit tumors, notably, as first shown by Wriston and his co- 
workers, enzymes from Esckerickia coli and other bacteria (6--8). Much remains 
to be understood, however, about the mechanism of asparaginase action in vivo 
and particularly the reasons for its high degree  of selectivity. Normal tissues may 
be affected briefly, as shown by inhibition of liver regeneration (9), but rapid 
recovery occurs and it appears  that no permanent toxicity results  (1,  10). 
Tumors vary sharply in sensitivity to asparaginase, in some, notably certain 
lymphomas, severe or even complete destruction is produced, while others are 
unaffected (1, 3). 
Earlier work has established that aspamginase-sensitive cells of Lymphoma 
6C3HED are L-asparagine dependent in tissue culture, while resistant variants 
are asparaglne independent (4). Asparagine is a constituent of most if not all 
proteins, and when deprived of the amino acid, protein synthesis in sensitive 
cells is inhibited, as has been demonstrated by Sobin and Kidd, and by others 
(11, 12). The present work extends from these basic findings. Its purpose has 
been to  examine the degree of depletion of blood  asparagine produced by 
asparaginase in  vivo,  and  to  identify metabolic characteristics of sensitive 
lymphoma cells which, by contrast with resistant cells and normal tissues, de- 
termine their destruction under such conditions. 
Materials and Methods 
Mice.---CSH or C3H/C57B1-F1 mice of either sex weighing 20-27 g were used. They were 
purchased from Microbiological Assodates, Bethesda, Md. 
Tunwrs.--The present studies have used, as before, cells of Lymphoma 6C3HED  (desig- 
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nated in the figures as "S") maintained as solid subcutaneous tumors and as ascites tumors in 
C3H  or  C3H/C57B1-F1  mice.  An  asparaginase-resistant  subline  (designated  "R"  in  the 
figures) was obtained at the start of the present experiments by treatment of a mouse bearing 
a  sensitive tumor with subcurative quantities of asparaginase and repeating this over five 
transfer generations. The subline, as others used earlier, is completely resistant and has main- 
tained the character continuously. In the absence of asparaginase treatment both the sensitive 
line and resistant sublines have the same growth rate in vivo (4). 
Asparaginase.--Agouti  serum  I,-asparaginase was  obtained as described in  references 8 
and 13. E. coli asparaginase has been generously provided by the Worthington Biochemical 
Company,  Freehold,  N.J.  The method of preparation is basically that of  Mashburn and 
Wriston (6). The preparation used contained 430 units/mg, assayed by the method described 
previously (14). The unit of asparaginase activity is that which hydrolyzes 1 #mole asparagine 
in 1 hr. 
Collection of Blood Samples.--To  collect volumes of blood of approximately  1 ml, mice 
are narcotized by carbon dioxide and blood drawn from the inferior vena cava into a syringe 
containing dried heparin. To collect blood for asparagine estimation in animals treated with 
agouti serum asparaginase, the narcotized mouse is placed on a board over a magnetic stirrer. 
Blood is withdrawen from the inferior vena cava into a  2.0 ml syringe containing a  small 
moving magnetic stirring bar, and initially filled to the 1.0 mi mark with 0.5 mg/ml p-chloro- 
mecuribenzoate (Mann Research Laboratories, Inc., N.Y.) in 0.15 ,i NaCL As blood enters 
the syringe it is immediately mixed with this solution and, as has been found in preliminary 
testing, the asparaginase is at least 96o70 inactivated. For animals treated with E. coli asparag- 
inase, 5-diazo-4-oxo-L-norvaline (the generous gift of Dr. R. E. Handschumacher) at 1 )<  10-3 
H was used as an inhibitor. The volume of blood entering the syringe is measured, the total 
contents expelled into 5 ml of 1 g/100 ml picric acid, and the syringe washed out in a further 
5mi. 
Preparation of Tissues for Assays.--Mice are killed by severing the neck and blood from 
tissues removed by blotting on gauze. After weighing, tissues are dropped into 10 ml of chilled 
picric acid solution contained in the 50 ml cup of a blendor, (Omnimix, Lourdes Instrument 
Corp. Brooklyn, N.Y.)  and homogenized at 16,000  rpm. for 2 rain, keeping the cup in ice. 
Meo~urement of Asparagine and Glutamine in Tissue Samples.--Detalls of the method de- 
veloped in our earlier work specifically for this purpose have been published (15). 
In tissue culture fluid the method is not always satisfactory due to the very high concen- 
tration of glutamine present. Asparagine is therefore measured after conversion to aspartic 
acid. Two 5-ml aliquots of tissue culture medium are removed, 0.2 ml of dialyzed agouti serum 
are added to one  (to convert asparagine to  aspartate),  an equal volume of 0.15 M sodium 
chloride to the other, and the mixtures are incubated at 37°C for 50 rain. Protein is precipi- 
tated by saturating with picrie acid,  and centrifuged down.  A  measured volume of super- 
natant is applied to a  8 x  1 cm column of Dowex 50W x 8 resin (H  +) and washed  through 
with water until the picnic acid is completely removed. Amino acids are eluted in N  NH4OH, 
and the eluate dried in a current of air. 
The amino acid residue is applied to 3  mm Whatman paper and subjected to high voltage 
electrophoresis (40 v/cm) in 4  X  10  -2 m phosphate buffer at pH 6.5. The acidic amino acids 
are  eluted,  and 2,4,6-trinitrophenyl derivatives prepared,  as  described  earlier  (15).  After 
ether extraction these are separated on paper by high voltage electrophoresis in 0.1 M acetic 
acid-pyridine buffer at pH 5.3.  The 2,4,6-trinitrophenyl derivative of aspartic acid moves 
more rapidly than any other colored spot and is easily identified. This is eluted in NaHCO~ 
solution  (1  g/100 ml)  and its concentration estimated spectrophotometrically at  340  m/*. 
Above 1/~g aspartic acid reproducibility is 4-3%.  Asparagine concentrations in the tissue 
culture medium are derived from differences in optical density readings between asparaginase- j.  D.  BgOO~rE  1057 
and nonasparaginase-treated  aliquots. Omitting the asparaginase step, this method has been 
used to measure aspartate concentrations in tissues homogenized in picric acid. 
Experiments  on Asparagine  and  Leucine  Metabolism  In  Vitro.--The purpose of these  ex- 
periments has been to measure the amount of free exogenous  asparagine  and  leucine within 
lymphoma ceils and at the same time to measure the rate of incorporation of the amino acids 
into the cell proteins. To do this ascites  cells washed in Eagle's basal medium (16) are sus- 
pended in 30 ml quantities of medium to which L-asparagine-14C  (Nuclear-Chicago Corp., 
Des Plaines, Ill.) and labeled leucine (L-leucine-a4C [UL] or L-leucine-4,5-H3, New England 
Nuclear Corp., Boston, Mass.) are added. The medium is contained in serum bottles at 37°C, 
gassed with 10% carbon dioxide in air, and gently agitated. At intervals 5.0 ml allquots are 
removed, transferred to chilled McNanght tubes (Arthur H. Thomas Co., Philadelphia, Pa.) 
and the suspensions  centrifuged immediately at 0°C and  1000 g. The packed cell volume is 
read after 10 rain. Incubation medium is removed and the walls of the tube washed with fresh 
unlabeled medium.  Distilled water is added  to the 1.0 ml mark and the cells are broken by 
the three cycles of freezing and thawing.  1 ml of 300/0 trichloracetic acid is then added  to 
precipitate proteins. After centrifngation the radioactivity of the supematant  is measured 
(0.1 ml in 2 ml ethanol and 15 ml toluene-Liquifluor) in a Tricarb  liquid scintillation spec- 
trometer (Packard  Instruments,  Downers Grove, Ill.). If similar readings are made on the 
free amino acids of the medium, the quantity of intracellular amino acid may be determined. 
It is necessary, however, to apply a  correction for amino acid trapped  in the extracelluiax 
space of the pellet and  this may readily be done when the volume of the space is known. 
Average extracellular spaces of 21.23% of the packed cell volume for sensitive cells and 18.19% 
for resistant cells are found by the use of Dextran-Carboxyl-14C (New England Nuclear Corp.). 
The protein precipitate from the lysed tumor cells is washed by the method of Sickevitz (17), 
dried and dissolved in NCS solub'flizer ( Nuclear-Chicago Corp.). Radioactivity is measured 
by liquid scintillation in Toluene-Liquifluor. Amino add analyses of hydrolyzates (18) of pro- 
teins prepared as described have been made in the Beckman Model 120C instrument. 
EXPERIMENTAL  RESULTS 
Blood Asparagine 
Mouse plasma contains a  low concentration  of asparagine,  which averages 
34.3 nmoles/ml, a figure very similar to that found in the rat, 38.1 nmoles/ml 
(Table I).  The asparagine level in the rabbit is rather higher, 54.9 nmoles/ml 
and appears more closely to resemble the figures reported in other species (19, 
20). Estimations in the whole blood of the mouse yield consistently lower con- 
centrations of asparagine than in the plasma, which is at least partly due to 
losses in the protein precipitate during  the estimation.  Nonetheless,  particu- 
larly in experiments employing asparaginase,  whole blood samples have been 
used; it is then possible to inactivate the enzyme as the sample is collected. As 
shown in Table I, blood asparagine levels in the mouse and plasma asparagine 
levels in the rat are remarkably stable under conditions of fasting. After 48 hr 
the levels in fasting animals do not differ significantly from those in animals 
on an unrestricted diet. 
When C3H mice are treated with asparaginase,  however, a marked fall in 
blood asparagine occurs. Results from experiments using agouti serum and E. 
coli asparaginase in doses which cause a moderate inhibition of tumor growth 1058  TUMOR  INHIBITION  BY  L-ASPARAGINASE 
are shown in Fig. 1. With agouti serum enzyme which is cleared slowly from the 
blood, in this experiment with a half-life of 11 hr, the blood asparagine remains 
depressed for at least 76 hr. With the E. coli enzyme, which had a  half-life of 
3 hr the level reaches normality at 44 hr.  The minimum blood levels in both 
TABLE I 
Asparagine Levds in Blood and Plasma of Different Species (nmoles/ml) 
Sample 
Normal plasma 
Normal blood 
After 24 hr fast 
After 48 hr fast 
I  Mouse  /  Rat 
34.3  4- 8.7  (6)  38.1  4- 9.2  (2) 
t2s.1 4-  1.7  (s) 
t21.8  4- 9.6  (3) (blood) 136.2 4- 8.9  (2) (plasma) 
[24.0  4- 6.0  (3) (blood)  [36.5  4-  7.1  (2)  (plasma) 
Rabbit 
54.9  ±  25.3  (8) 
Figures shown in this and other tables are averages with standard deviations.  Figures in 
parenthesis indicate the number of animals examined. 
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FIG. 1. Blood asparagine levels in mice injected  with  asparaginase.  C3H mice were in- 
jected  with  0.5 ml agouti  serum  (170 units of asparaginase)  intraperitoneally,  or 0.5  ml 
Ringer's solution containing E. coli asparaginase  (150 units)  intravenously. 
Each point represents the result in an individual mouse of a group injected with the same 
enzyme preparation. 
cases  (below  1.0  nmole/ml)  are much below  those  necessary  to support  the 
growth of 6C3HED  cells  in vitro,  as later  experiments  will  show.  Simultane- 
ously  with  changes  in  the  blood,  asparaginase  causes  a  marked  change  in 
asparagine content of the tissues. 
Asparagine Levels of Normal Mouse Tissues and of 6C3HED Lymphomas, and J.  D.  BROOME  1059 
tke Effect of Asparaginase  Treatment on These.--Normal tissues of the mouse 
vary considerably in asparagine content as shown in Table II. The low levels in 
the kidney and liver are possibly related to the fact that these two organs con- 
tain asparaginase while the others do not? In solid 6C3HED lymphomas a high 
asparagine content is found, which is slightly more in the resistant variant than 
in the original asparaginase-sensitive tumor (125.1 and 143.7 nmoles/g respec- 
tively). The levels are similar to those in normal lymphoid tissue. 
Asparaginase causes a marked fall in the asparagine content of normal tissues, 
examined 18-24 hr after treatment. In relation to the initial levels a more severe 
depletion occurs in the kidney than in the liver (to 24.8 and 40.3 % respectively) 
and in the spleen as compared with the thymus (to 21.1 and 36.5 %). 
TABLE H 
Asparagine Content of Mouse Tissues before and during Asparaginase Treatment 
Tissue 
Liver 
Kidney 
Spleen 
Thymus 
Lymphoma 6C3HED (sensitive) 
Lymphoma 6C3HED (resistant) 
Asparaglne content (nmoles/g  wet weight) 
Normal 
29.3  ±  8.9  (6) 
55.6  ±  9.1  (5) 
124.0 ±  36.8  (9) 
162.3 ±  44.2  (6) 
125.1 -4- 23.0  (10) 
143.7 -4- 33.9  (8) 
20-24 hr after asparagiuase 
11.8 ±  5.2  (6) 
13.8 ±  7.6  (5) 
26.1  -4-  10.5  (10) 
59.2  -4-  17.9  (5) 
59.2  ±  1.5  (4) 
17.'/  ±  9.6  (4) 
Within 1 hr of intravenous injection Of asparaginase, the asparagine content 
of lymphoma tissue falls to approximately 20 nmoles/g, ~6 of the initial level 
(Fig. 2). Surprisingly this value is virtually the same in both sensitive and re- 
sistant forms of 6C3HED. In resistant tumors the level falls even lower during 
the next 20 hr, to 17.7 nmoles/g, a change which has no detectable effect on the 
growth rate of palpable tumors and produces no microscopic evidence of damage 
(4). By contrast, sensitive tumors with similar asparagine levels show marked 
cytotoxic effects at 6 hr, and at 20 hr, by which time the free asparagine level 
has risen to 58 nmoles/g, they are substantially necrotic (1). The later rise in 
asparagine content of sensitive tumors may be due at least in part to protein 
breakdown and failure of utilization of synthesized amino acids. In addition to 
asparagine,  certain other amino acids accumulate in sensitive lymphomas at 
this time. For instance, in one experiment serine increased by a factor of 2.4, 
20 hr after treatment, lysine by 1.9, and threonine by 1.9, from control levels of 
951,573, 1015 nmoles/g respectively.  ~ Increases in the content of aspartic acid 
1 Broome, J. D.  Unpublished observations. 
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and glutamine,  intermediates  in asparagine biosynthesis also occur. These will 
be discussed more fully later. 
It is thus apparently paradoxical that sensitive  tumor cells die with a  level 
of total  free  asparagine  which  is  adequate  for  the  growth  of resistant  cells. 
Further in vitro experiments, however, make it possible to provide an explana. 
tion for this finding. 
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FIG. 2.  Free asparagine content  of 6C3HED  tumors treated with L-asparaginase. Subcu- 
taneous tumors were used 8-9 days after implantation  of mice with approximately  2 million 
lymphoma cells. Mter careful blotting on gauze they weighed approximately  500 mg each. 
"S" indicates the asparaginase-sensitive tumor and "R" the resistant  variant.  For measure- 
ment of asparagine content  at 1 and 3 hr,  1.0 ml agoufi serum  (360-420 units)  was given 
intravenously. The number of animals used and standard deviations were: 1 hr, S-(ll) 4- 1.03; 
R-(4)  4- 1.10. 3 hr, S-(4) -4- 0.21; R-(4)  4-  1.14. For measurements  after 20 hr treatment, 
asparaginase  was  given  intraperitoneally. 
Utilization  of Exogenous Asparagine for  Protein Synthesis  by  Lymphoma 
Cells.--As has been shown in earlier work, evidence bearing on the in vivo effect 
of asparaginase  on lymphoma cells can be obtained in tissue  culture  systems 
containing low concentrations of asparagine.  It has now been possible by this 
means to study the effects of milder deprivation  of the  amino acid than  can 
readily be demonstrated during asparaginase treatment in vivo. 
Even when  the medium contains  an amount of asparagine which supports 
optimal growth (3.79 X  10  ~  M) the amount of exogenous free asparagine within 
sensitive cells is less than in resistant (261.4 and 297.8 nmoles/1 ml cell volume 
respectively),  and its decline with decreasing  asparagine concentration  in the J.  D.  BROOME  1061 
medium is considerably more rapid (Table iII). After inhibition of protein syn- 
thesis by cycloheximide, however, both kinds of cell show the same capacity to 
concentrate  the  amino  acid.  These  results  are  consistent  with  the view that 
sensitive cells utilize asparagine entering the cell from the medium at a  faster 
rate than  is the case with resistant  cells.  The extensive incorporation  of this 
amino acid into cellular proteins is shown in Fig. 3. It is also clear that sensitive 
cells incorporate  a  significantly greater  amount of exogenous asparagine  into 
protein than do resistant cells. 
Total protein synthesis of the lymphoma cells has been measured from the 
TABLE III 
Exogenous-Free Asparagine  in  6C3HED  Lymphoma  Calls Incubated  in  Eagle's  Medium 
In medium 
In sensitive cells 
In resistant ceils 
4.5 
4.4 
20.0 
Asparagine concentration  in nmoles/l ml 
7.9 
15.5 
50.5 
12.9 
32.2 
77.7 
21.2 
135.8 
162.2 
37.9 
261.4 
297.8 
Cycloheximide 
4.5 
43.7 
39.5 
The measurement  of exogenous asparagine in lymphoma cells is described in the section 
entitled  Materials  and Methods;  results  are obtained  after  10 rain of incubation.  In both 
sensitive and resistant  cells maximum values for intracelhlar asparagine are  found at this 
time, regardless of the external concentration  used. At later  times values are  less  reliable 
due to changes in the amino acid content of the  medium. Cycloheximide (Sigma Chemical 
Co., St. Louis, Mo.) is  dissolved in Eagle's  medium to give a  concentration  of 25 mg/100 
ml. Ascites cells are washed in this  before beginning the incubation.  During incubation in- 
corporation of asparagine and leucine into  protein  is completely inhibited,  but no  increase 
in the number of cells permeable to trypan blue is found. 
rate of incorporation of leucine when this amino acid is at constant concentra- 
tion  (2  X  10  -~ M)  in  the  medium.  In  sensitive  cells,  although  the  internal 
leucine pool remains almost constant (749-807 nmoles/ml), incorporation  into 
protein decreases sharply when the asparagine concentration of the medium  is 
reduced to 7.9 X  10  -8 M. At 4.5  X  10  -6 %  the lowest concentration obtained, 
leucine incorporation in resistant cells is normal (Fig. 4). 
A combination of these results, by double labeling techniques, make it possi- 
ble to draw certain important conclusions. It will be seen from Fig. 5 that the 
amount  of exogenous asparagine  incorporated  into  the cell proteins  for each 
unit of exogenous leucine is greater in the sensitive than in the resistant  cells 
at the highest asparagine concentration in the medium (ratios of 0.41 and 0.29 
respectively).  In resistant  cells this ratio falls to 0.05  in an apparently linear 
fashion as the external  asparagine  concentration decreases.  In sensitive  cells, 
however, a critical change in total leucine incorporation occurs when the aspara- 
gine: leucine ratio reaches 0.23. At 12.9  X  10-6M asparagine,  total leucine in- 1062  T~OR  INHIBITION BY L-ASPARAGINASE 
corporation is normal, at 7.9 X  10  --e ~  total incorporation falls by 35 %. It is 
clear, therefore, that sensitive cells have only a  limited ability to substitute 
endogenous for exogenous asparagine in protein synthesis, and that when this 
limit is reached, protein synthesis is inhibited. 
If resistant lymphoma cells continue to make protein with the same aspara- 
gine content, it follows from the results just described that they readily replace 
exogenous asparagine with endogenous, as the external concentration of the 
amino acid decreases. Furthermore, for the result to be at all detectable the 
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FIO. 3.  Incorporation  of exogenous asparagine into proteins of Lymphoma  6C3I-IEI). 
Method as described  earlier, measuring  incorporation in I  hr of incubation. With resistant 
cells (see reference 12)  the rate of incorporation is linear in the 1st hr of incubation. With 
sensitive cells when low asparagine concentration limits utilization, the rate decreases after 
the first 10 rain. 
endogenous asparagine used in protein synthesis cannot be in equilibrium with 
the pool of asparagine which has entered the cells from the medium. 
Asparagine is not a rare amino acid in proteins; when measured it has been 
found on average in approximately the same amount as aspartic acid (21),  and 
in proteins labeled in the present experiments in amounts which are from 30- 
40% of their leucine content. Amino acid analyses of hydrolyzates of proteins 
of the resistant lymphoma cells whether grown under standard conditions in 
vivo or during asparaginase  treatment over a  whole transfer generation are, 
however, identical. Particularly the ratio  of aspartate  (which  represents the 
sum of asparagine and aspartate in  the original protein) to leucine (1.01 and 
1.02  respectively)  and  other  amino acids is  the  same under  the  two condi- 
tions. Sensitive cells not treated with asparaginase, contain a  slightly higher 
aspartate:leucine ratio (1.11)  than do resistant cells, but in general their com- 
position is similar. J.  D.  BROOm~  1063 
The greater utilization of endogenous asparagine for protein synthesis by re- 
sistant than by sensitive cells could be due to a higher de novo rate of synthesis 
or to a decrease in alternative forms of utilization of the amino acid. The latter 
possibility will next be examined. 
Fate of Asparagine in Lymphoma Cells.--The  asparagine incorporated into 
protein by Lymphoma 6C3HED remains within the cells; precipitates of me- 
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FIO. 4. Incorporation of exogenous  leucine into proteins of Lymphoma 5C3HED. 
dium in which lymphoma cells have been incubated with asparagine-14C, show 
no protein-bound label. In lymphoma cell proteins, furthermore, those contain- 
Lug asparagine do not have a particularly rapid turn-over rate. After labeling 
with asparagine-14C in vivo, lymphoma cells incubated for 1 hr in medium con- 
mining  a  high  concentration  of unlabeled asparagine  (3 X  10  -4 ~) lost less 
than 0.5 % of their label. In the cell proteins exogenous asparagine does not ap- 
pear as aspartate.  Proteins from both sensitive and resistant lymphoma cells 
incubated  in  asparagineJ4C  have been hydrolyzed to amino  acid and  small 
peptide fragments by pronase (22) and these subjected to high voltage electro- 
phoresis.  At  pH  1.9, approximately  3~  of  the  label  has the  mobility  of 1064  TUMOR INHIBITION BY  L-ASPARAGINASE 
asparagine, while at pH 6.5 no detectable amount of label is found as asparfic 
acid or other substance with a negative charge. 
No utilization of labeled asparagine for any purpose other than protein syn- 
thesis has been observed. High voltage electrophoresis at pH 6.5, 4.9, and 1.9 of 
protein-free lysates from cells incubated in  asparagine-14C  show 94%  of the 
label migrates in a fashion indistinguishable from asparagine. 6 %  of the label 
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Fio. 5. Ratio of exogenous  asparagine to leucine in proteins of Lymphoma 6C3HED. 
is in a substance or substances with about ~  the mobility of asparagine at pH 
1.9.  Peptides migrate at this rate. No substantial amount of asparagine is in- 
corporated into nucleotides. When precipitates of lymphoma ceils in 6%  tri- 
chloracetic acid have been heated at 90°C for 15 rain, which hydrolyzes more 
than 80% of the DNA, only 1.1% of their radioactivity has been lost to the 
solution. Asparagine is not metabolized to carbon dioxide. In an experiment in 
which cells took up 10.2 nmoles of labeled asparagine per milliliter of medium, 
less than 0.1%  of the label was found in carbon dioxide, collected in alkali, 
after acidification of the medium. 
These results show that in both resistant and sensitive cells utilization of any ~'.  V.  BROOME  1065 
substantial amount of asparagine is by only one pathway, namely protein syn- 
thesis. A difference between these cells, however, is found in the rate of aspara- 
gine loss to medium in which they are incubated. 
Loss of Asparagine from Lymphoma Cells during Incubation In Vitro.--When 
incubated in Eagle's medium, resistant 6C3HED cells liberate considerably more 
asparagine into the medium than do sensitive cells (Table IV), by a factor of 
4.4 at 1 hr and by 7.0 at 24 hr. At the later time, however, only approximately 
TABLE IV 
Liberation  of Asparagine  and  Aspartate  into  Eagle's  Medium  by  6C3HED  Cells 
Incu-  Type of  Cells imper- 
bation  lymphoma  Asparagine  Aspartic acid  meable to 
period  cell  trypan blue 
kr  nraoles/1 ntm  s #acked cells  % 
1  97-4-1 
24 
Sensitive 
Resistant 
Sensitive 
Resistant 
0.25  4-  0.02  (4) 
1.09  4-  0.13  (3) 
3.05 Average =  2.87 
2.69 
22.5 
17.9  Average =  20.2 
0.58  4-  0.09 
0.22  4-  0.05 
17.72  Average =  18.73 
19.73 
5.59 Average =  8.34 
11.09 
98-4-  1 
50 
45 
70 
72 
Cells were obtained from ascites tumors. In experiments using  incubation for I  Jar, an 
initial 10 mill was allowed for equilibration bdore measurements were made. In experiments 
using 24 hr of incubation, controls were made in which replicate cultures were subjected to 
2 cycles of freezing and thawing at the beginning of the experiment to cause lysis of the lym- 
phoma cells. No increase in asparagine or aspartic acid content of the medium was found 
after 24 hr of incubation. 
50% of the sensitive cells appear viable, while 70% or more of the resistant 
cells survive. 
Some of the asparagine liberated by the lymphoma cells is derived from cellu- 
lar protein, which is to be expected from the relatively rapid rate of protein 
turn-over known to occur in mammalian cells (23). In resistant cells prelabeled 
with asparagine-t4C  in vivo, 0.27 4- 0.05 % of protein radioactivity was recov- 
ered in free asparagine of the medium after 1 hr of incubation. With sensitive 
cells 0.03 ±  0.02 % was recovered. Although the asparagine content of the pro- 
teins from which this asparagine is derived is not known, estimates based on the 
total asparagine-aspartate content of the lymphoma cell proteins indicate that 
proteolysis does not account for more than ~0  of the free asparagine liberated 
into the medium by resistant cells, and a considerably smaller amount in the 
case of sensitive cells? It is therefore likely that the remainder is synthesized 
de novo. 
s 1 mm  s of packed cells contains 0.116 mg protein, of which approximately 5% is aspara- 
gine-aspartate, that is 4 X  10  -8 moles. 1066  TUMOR  INHIBITION BY  L-ASPARAGINASE 
In contrast to the findings just described, considerably more aspartic acid is 
liberated into the medium by sensitive than by resistant cells. At 1 hr, liberation 
of this amino acid by the two kinds of cell differs by a factor of 2.6 and at 24 hr 
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FIG. 6. Asparagine synthesis by pH 5 enzyme of cells of Lymphoma 6C3HED. Lymphoma 
cells were suspended in 5 volumes of 0.35 z-buffered sucrose (solution A, reference 25) and 
lysed by three cycles of freezing and thawing. The suspension was centrifuged at 12,000 g 
for 30 min, the supematant diluted with 3 volumes of sucrose solution B and centrifuged at 
120,000 g for 120 rain. The supematant from this stage was brought to pH 5.2 with dilute 
acetic acid and the precipitate which formed was centrifuged down at 10,000 g for 10 mill. 
The precipitate was dissolved in glutathione-versene-tris buffer (pH 7.5) according to Patter- 
son and Orr (24), and kept frozen at --20°C till use. In assays the incubation mixtures con- 
sisted of 1.0 ml 1.5 X  10  -s ~ T.-aspaxtic acid with 0.25 #c L-aspartic acid --'4C [UL] (New 
England Nuclear Corp.), 2 X  10  -2 M L-glutamine (or 3 X  10  -s M NH4CL), 1 X  10  -~ ~t po- 
tassium ATP  (Mann Research Laboratories, Inc.), 1 X  10  -2 M magnesium chloride, 0.1 - 
Tris, final pH 8.0. 0.2 ml enzyme preparation  was added to  this. The reaction was stopped 
by heating aUquots in a boiling water bath for 2 rain. Asparagine and aspartate  were sepa- 
rated by high voltage electrophoresis at pH 6.5, the location of each was determined by radio- 
autography, and radioactivity on the paper  was measured by liquid  scintillation counting. 
Protein  was estimated  by a modification of the Lowry method (26). 
by 2.2. Further experiments show that aspartic acid is an asparagine precursor, 
and  that  considerable changes  in intracellular aspartic  acid  levels  occur  in 
lymphoma cells treated with asparaginase in vivo. 
A sparagine Biosynthesis in Cell-Free Systems.--Extracts  of resistant 6C3HED 
cells but not of sensitive cells of this line synthesize asparagine in a  system 
modified from that described by Patterson and Orr (24). In this a  "pH 5  en- 3.  D.  BROO~rE  1067 
zyme" preparation  (25)  is incubated with aspartic  acid-14C, glutamine, and 
ATP in the presence of magnesium ions. Labeled asparagine formed is separated 
from aspartic acid by high voltage electrophoresis. That the reaction product 
is indeed asparagine has been shown by its mobility on high voltage electro- 
phoresis at pH 6.5 and pH 1.9, and by its conversion to aspartic acid (identified 
by similar means) by agouti serum asparaginase. As shown in Fig. 6, extracts 
from resistant cells synthesize asparagine at a constant rate for 60 rain, while 
those from sensitive cells  are completely inactive. A higher rate of synthesis 
has been found with two preparations from ascites tumor cells (34.8 and 35.1 
nmoles asparagine/mg protein/hr)  than with a  preparation  from solid sub- 
cutaneous tumors (10.3). Ammonium ion will substitute for glutamine; initially 
the reaction rate is slower but subsequently it reaches the same rate as that 
found using glutamine. Asparagine synthesis is inhibited to 74.3 % of the maxi- 
mum rate by added asparagine at 2.5 X  10  -4 M, to 19.9 % at 2.5 X  10  -8 M, and 
to 7.8% at 1.0 X  10  -2 ~.4 
During asparaginase treatment in vivo both sensitive and resistant 6C3HED 
ceils show increases in substances found to be asparagine precursors, but not in 
their content of free a-amino nitrogen as might be expected if this were due to 
ceil autolysis. In sensitive tumors the aspartic acid level increases to 12.0 times 
normal 3 hr after treatment (Fig. 7). In resistant tumors the level increases 2.9 
times, and after 20 hr is still raised 1.8 times. These changes have not been 
found with other agents which produce cytotoxicity, for instance, in an experi- 
ment in which pairs of mice were given 58 mg/kg cyclophosphamide or 2.2 
mg/kg colchicine intravenously, the average apartic acid level in lymphomas of 
the former was 129% of control values 4 hr after treatment, and in the latter 
101%. 
During asparaginase treatment glutamine levels rise in both kinds of lym- 
phoma cell, in resistant tumors the increases (to 195% at 3 hr, and 111% at 24 
hr) are again less than in the sensitive. In the latter the rise is progressive and 
reaches 420% at 20 hr, which may be related to the marked cytotoxic changes 
at this time. Such changes have been observed under different conditions by 
Roberts and Simonsen in several regressing tumors (28). 
DISCUSSION 
The results described show that in mice asparaginase treatment causes a pro- 
found fall in the normally constant blood asparagine levels. Concomitantly the 
4 The presence of aspamgine synthetase is not limited to lymphomas  in which resistance 
had developed as a result of asparaginase treatment in vivo. Preparations of pH 5 enzyme 
from four different mouse lymphoma lines intrinsically resistant to asparaginase synthesize 
asparagine at rates of 8.3-128.0 nmoles/mg protein per hour. By contrast, no synthetase 
activity has been found in extracts of cells of two further lines of asparaginase-sensitive 
lymphomas. 1068  TU~OR  INHIBITION  BY  L-ASPAEAGINASE 
total  free  asparagine  content  of both  normal  and  lymphomatous tissue  de- 
creases.  But it is clear that the degree of fall bears no relation to the amount of 
cellular damage which occurs. The liver, for instance,  at 11.8 nmoles/g has a 
level  of  asparagine  lower  than  ever  found  in  lymphoma  tissue.  Sensitive 
lymphomas maintain an average level of 19.4 nmoles/g 1 hr after treatment, 
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Fla.  7.  Effect of L-asparaginase treatment  on amino acid levels in  6C3HED tumors. 
Experimental animals were treated as described in Fig. 2, with 1.0 ml agouti serum (340 
units). Total free a-amino nitrogen was measured by the ninhydrin reaction (27) on picric 
acid supernatants used for assay of asparagine and other amino acids. Results in each case 
represent averages of three to six experiments. 
very little different from that in resistant tumors; at 3 hr the two kinds have 
equal levels. 
That resistant 6C3HED cells are able to continue unimpaired growth under 
these conditions depends on several factors, first, that they have a high rate of 
asparagine synthesis. This is shown by their ability to substitute  endogenous 
for exogenous asparagine in freshly formed proteins when deprived of an ex- 
ternal  source  of  the  amino  acid,  and  at  the  same  time  to  lose  substantial 
amounts of asparagine to the medium. Sensitive 6C3HED cells appear to have 
some capacity to substitute  endogenous for exogenous asparagine  (change of 
leucine: asparagine ratio from 0.41  to 0.23  with a normal rate of leucine incor- j.  D.  BROOM~  1069 
poration into protein), and to lose more asparagine to the medium than can be 
accounted for by proteolysis, but in both cases this is considerably less than 
with resistant cells. However, no asparagine synthetic system has been demon- 
strated in extracts of sensitive 6C3HED cells or cells of two other asparaginase- 
sensitive lines. But an active system has been obtained in pH 5 enzyme prepara- 
tions from asparaginase-resistant 6C3HED  cells,  which utilizes aspartic acid, 
glutamine, and ATP. Asparagine concentration, itself, may act as a rate control 
mechanism for the synthetase. An apparently similar asparagine synthetase 
has been obtained from the cells of four lymphoma lines which are intrinsically 
resistant to asparaginase, and from certain normal tissues. Whether the presence 
of this system is a consistent characteristic of asparaginase-resistant cells and its 
absence characteristic of asparaginase-sensitive cells remains to be determined. 
It is not unlikely, however, that in either kind of cell there are other routes for 
asparagine synthesis. Arlin has shown a different synthetic system in embryonic 
chick liver (29) and in bacteria others are known (30, 31). 
A further factor responsible for the asparaginase resistance in  6C3HED-R 
lymphoma cells is their ability to conserve synthesized asparagine for protein 
synthesis. To be able even to detect substitution of exogenous by endogenous 
asparagine in resistant cells,  the rate  of exchange between intra- and extra- 
cellular asparagine when the amino acid is at a low level in the medium must 
be slower than the rate of asparagine utilization. Relative impermeability, how 
ever,  does  not  explain the observation that in solid tumors in vivo, protein 
synthesis is strongly inhibited in sensitive cells at levels of total cell asparagine 
which are adequate for normal synthesis in resistant cells. This raises the possi- 
bility that there is a linkage between sites of asparagine synthesis and utilization 
in resistant cells, which allows synthesized asparagin¢ to be used preferentially 
for protein formation before equilibration with  the whole cell pool.  Such  a 
system could be of great importance for protein synthesis in  tissues such as 
the liver and kidney which normally contain asparaginase, and in these and 
others  during  asparaginase  treatment.  It  may also  be  important in  vitro: 
Eagle and his coworkers have obtained evidence of the preferential use of en- 
dogenous over exogenous asparagine in protein formation by HeLa and other 
asparagine-independent cell lines (32). 
In addition to inhibiting protein synthesis, it has been shown that aspara- 
ginase causes changes in the intracellular levels of other amino acids, particu- 
larly, in sensitive cells, the accumulation of aspartic acid to 12 times the nor- 
mal. It has not been possible to test the isolated effect of this change: no com- 
parable rise in intracellular aspartic acid occurs when cells are incubated  in 
high concentrations of the amino acid (to 3.0 X  10  -s ~). The role of these effects 
in causing cytotoxicity cannot, therefore, be excluded, and indeed it is possible 
that  cytotoxicity from  asparaginase  treatment  is  due  to  a  combination  of 
separate events. Nonetheless, inhibition of protein synthesis is likely to be of 1070  TD3~OR INHIBITION BY L-ASPARAGINASE 
particular importance, and may affect a number of metabolic control mecha- 
nisms. Alkaline ribonuclease, for instance, is activated within 1 hr of aspara- 
ginase treatment of sensitive tumors (33). Further, it may be that inhibition of 
protein synthesis by asparaginase is selective so that particular essential cell 
proteins are no longer formed. In cell-free bacterial systems asparaginase has 
been shown to inhibit the formation of an asparagine-rich but not of an aspara- 
gine-poor protein  (34).  These later effects of asparaginase  treatment  are  at 
present under investigation. 
SUMMARY 
•-asparaginases  of agouti serum and Escherichic~ coli cause a profound lower- 
ing in the level of free asparagine in the blood of treated mice and also in the 
tissues. During treatment, normal tissues and resistant 6C3HED  lymphomas 
survive unharmed with intracellular asparagine levels which are critically low 
for sensitive lymphomas.  An  explanation for this contrast between the  two 
types of lymphoma is provided by the finding that resistant cells have not only 
a higher asparagine synthetic capacity than sensitive cells but appear able to 
utilize  endogenous  asparagine  preferentially for protein  synthesis.  Cell-free 
extracts of resistant ceils contain an asparaginase synthetase, but this is not 
found in preparations from sensitive cells. 
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